AG
MLNT

Aperio Group’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Aperio Group’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,053
Closed -$7K – 2995
2019
Q2 		$7K Buy
+1,053
New +$7K ﹤0.01% 2833